Last reviewed · How we verify
Pneumococcal vaccine GSK513026 — Competitive Intelligence Brief
phase 2
Biologic
Live · refreshed every 30 min
Target snapshot
Pneumococcal vaccine GSK513026 (Pneumococcal vaccine GSK513026) — GlaxoSmithKline.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Pneumococcal vaccine GSK513026 TARGET | Pneumococcal vaccine GSK513026 | GlaxoSmithKline | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Pneumococcal vaccine GSK513026 CI watch — RSS
- Pneumococcal vaccine GSK513026 CI watch — Atom
- Pneumococcal vaccine GSK513026 CI watch — JSON
- Pneumococcal vaccine GSK513026 alone — RSS
Cite this brief
Drug Landscape (2026). Pneumococcal vaccine GSK513026 — Competitive Intelligence Brief. https://druglandscape.com/ci/pneumococcal-vaccine-gsk513026. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab